Valuation: Convatec Group PLC

Market Cap 5.63B 4.95B 4.61B 4.23B 7.95B 540B 8.05B 54.79B 21.4B 267B 21.14B 20.69B 922B P/E 2026 *
20.4x
P/E 2027 * 16x
Enterprise Value 6.83B 6.01B 5.59B 5.13B 9.64B 655B 9.77B 66.46B 25.96B 324B 25.65B 25.09B 1,118B EV / Sales 2026 *
2.66x
EV / Sales 2027 * 2.44x
Free-Float
95.19%
Yield 2026 *
2.72%
Yield 2027 * 3.05%
1 day+0.38%
1 week+0.38%
Current month+3.84%
1 month+3.57%
3 months-0.97%
6 months-8.67%
Current year-10.14%
1 week 11.24
Extreme 11.24
11.77
1 month 11.14
Extreme 11.14
11.94
Current year 10.45
Extreme 10.45
14.09
1 year 10.45
Extreme 10.45
14.09
3 years 9.9
Extreme 9.9
16.65
5 years 8.69
Extreme 8.69
16.65
10 years 0
Extreme 0
18.52
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%+0.38% - - 5.63B
+2.31%+3.91%-16.40%-6.23% 180B
+1.77%+1.90%-7.71%-4.11% 107B
+0.79%+2.74%+9.12%+66.71% 60.29B
+0.67%-1.94%+27.88%+55.85% 50.19B
+2.10%+3.63%-12.50%-43.55% 43.08B
+3.59%+3.55% - - 32.77B
+3.07%-2.47%-17.55%-42.93% 27.61B
+0.39%-6.66%+27.58%-7.34% 23.1B
+2.03%+2.25%-3.19%-4.56% 20.86B
Average +1.70%-2.24%+0.90%+1.73% 60.44B
Weighted average by Cap. +1.87%-0.40%-4.44%+3.80%

Financials

2026 *2027 *
Net sales 2.57B 2.26B 2.1B 1.93B 3.62B 246B 3.67B 24.96B 9.75B 122B 9.63B 9.42B 420B 2.74B 2.41B 2.24B 2.06B 3.86B 263B 3.91B 26.63B 10.4B 130B 10.28B 10.05B 448B
Net income 275M 242M 225M 207M 388M 26.38B 393M 2.68B 1.05B 13.03B 1.03B 1.01B 45.03B 354M 311M 290M 266M 499M 33.93B 506M 3.44B 1.34B 16.76B 1.33B 1.3B 57.92B
Net Debt 1.2B 1.05B 982M 902M 1.69B 115B 1.72B 11.67B 4.56B 56.81B 4.5B 4.41B 196B 1.03B 909M 846M 777M 1.46B 99.19B 1.48B 10.06B 3.93B 48.98B 3.88B 3.8B 169B
Logo Convatec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,910
Date Price Change Volume
28/07/26 USD 11.74 +0.38% 18,672
24/07/26 USD 11.70 +2.63% 16,448
23/07/26 USD 11.40 -2.56% 19,240
22/07/26 USD 11.70 +0.95% 16,433
21/07/26 USD 11.59 -0.94% 53,744
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
2.882USD
Average target price
3.986USD
Spread / Average Target
+38.32%

Quarterly revenue - Rate of surprise